TY - JOUR
T1 - Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians
T2 - Findings from the UK Biobank population-based cohort study
AU - Muilwijk, Mirthe
AU - Ho, Frederick
AU - Waddell, Heather
AU - Sillars, Anne
AU - Welsh, Paul
AU - Iliodromiti, Stamatina
AU - Brown, Rosemary
AU - Ferguson, Lyn
AU - Stronks, Karien
AU - van Valkengoed, Irene
AU - Pell, Jill P.
AU - Gray, Stuart Robert
AU - Gill, Jason Martin Regnald
AU - Sattar, Naveed
AU - Celis-Morales, Carlos
N1 - Funding Information: In conclusion, South Asians have a higher risk of CVD mortality and incidence but a lower risk of cancer mortality and incidence compared with white Europeans. Although T2D was associated with a higher risk for all-cause mortality and CVD incidence and mortality, in both white Europeans and South Asians, the risk experienced by South Asians with T2D was higher than their white European counterparts. We are grateful to UK Biobank participants. This research has been conducted using the UK Biobank Resource under application number 7155. UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government, and the Northwest Regional Development Agency, and is funded by the Welsh Government and the British Heart Foundation. JMRG, NS and CC-M contributed equally. Contributors MM, FH, HW, AS, PW, SI, RB, LF, KS, IvV, JPP, SRG, JMRG, NS, and CC-M reviewed the manuscript and approved the final version to be published. MM, FH, and CC-M performed the statistical analyses. MM, FH, JMRG, NS, and CC-M contributed to the study conception and design, advised on all statistical aspects, and interpreted the data. MM, FH, and CC-M drafted the manuscript. MM, FH, JPP, NS, JMRG, and CC-M are the guarantors of this work, and as such had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Funding This work was supported by the Health Behaviours & Chronic Diseases, Amsterdam Public Health. MM received a travel grant. Competing interests None declared. Patient consent for publication Not required. Ethics approval The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee, and all participants provided written informed consent to participate in the UK Biobank study. The study protocol is available online ( http://www.ukbiobank.ac.uk/ ). Provenance and peer review Not commissioned; externally peer reviewed. Data availability statement Data may be obtained from a third party and are not publicly available. Publisher Copyright: © © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/12/17
Y1 - 2019/12/17
N2 - Objective To investigate whether the health implications of having type 2 diabetes (T2D) were different in South Asian compared with white European participants. Research design and methods Prospective data from UK Biobank were used, and 457 935 participants of white European and 7102 of South Asian background were included. Cox proportional regression was performed to investigate the association between T2D and health outcome by ethnicity. Results Over a mean of 7.0 years (IQR 6.3-7.6) of follow-up, 12 974 participants had died, and 30 347 and 27 159 developed cardiovascular disease (CVD) and cancer, respectively. South Asians had a higher risk for CVD mortality (HR: 1.42, 95% CI 1.07 to 1.89) and incidence (HR: 1.78, 95% CI 1.63 to 1.94), but a decreased risk for cancer mortality (HR: 0.59, 95% CI 0.41 to 0.85) and incidence (HR: 0.80, 95% CI 0.70 to 0.92) compared with white Europeans. Compared with individuals without T2D, both white Europeans and South Asians with T2D had a higher risk for all-cause mortality (1.59 (1.48 to 1.71) vs 2.83 (1.76 to 4.53)), CVD mortality (2.04 (1.82 to 2.28) vs 4.40 (2.37 to 8.16)) and CVD incidence (1.37 (1.31 to 1.44) vs 1.60 (1.31 to 1.95)), respectively. However, the magnitude of the risk was higher for South Asians than white Europeans. Conclusions Although T2D was associated with a higher risk for all-cause mortality and CVD incidence and mortality, in both white Europeans and South Asians, the risk experienced by South Asians with T2D was higher than their white European counterparts.
AB - Objective To investigate whether the health implications of having type 2 diabetes (T2D) were different in South Asian compared with white European participants. Research design and methods Prospective data from UK Biobank were used, and 457 935 participants of white European and 7102 of South Asian background were included. Cox proportional regression was performed to investigate the association between T2D and health outcome by ethnicity. Results Over a mean of 7.0 years (IQR 6.3-7.6) of follow-up, 12 974 participants had died, and 30 347 and 27 159 developed cardiovascular disease (CVD) and cancer, respectively. South Asians had a higher risk for CVD mortality (HR: 1.42, 95% CI 1.07 to 1.89) and incidence (HR: 1.78, 95% CI 1.63 to 1.94), but a decreased risk for cancer mortality (HR: 0.59, 95% CI 0.41 to 0.85) and incidence (HR: 0.80, 95% CI 0.70 to 0.92) compared with white Europeans. Compared with individuals without T2D, both white Europeans and South Asians with T2D had a higher risk for all-cause mortality (1.59 (1.48 to 1.71) vs 2.83 (1.76 to 4.53)), CVD mortality (2.04 (1.82 to 2.28) vs 4.40 (2.37 to 8.16)) and CVD incidence (1.37 (1.31 to 1.44) vs 1.60 (1.31 to 1.95)), respectively. However, the magnitude of the risk was higher for South Asians than white Europeans. Conclusions Although T2D was associated with a higher risk for all-cause mortality and CVD incidence and mortality, in both white Europeans and South Asians, the risk experienced by South Asians with T2D was higher than their white European counterparts.
KW - ethnic differences
KW - mortality
KW - type 2 diabetes
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077126749&origin=inward
UR - http://www.scopus.com/inward/record.url?scp=85077126749&partnerID=8YFLogxK
U2 - https://doi.org/10.1136/bmjdrc-2019-000765
DO - https://doi.org/10.1136/bmjdrc-2019-000765
M3 - Article
C2 - 31908795
SN - 2052-4897
VL - 7
JO - BMJ open diabetes research and care
JF - BMJ open diabetes research and care
IS - 1
M1 - e000765
ER -